E-viri
Recenzirano
Odprti dostop
-
Muecksch, Frauke; Wang, Zijun; Cho, Alice; Gaebler, Christian; Ben Tanfous, Tarek; DaSilva, Justin; Bednarski, Eva; Ramos, Victor; Zong, Shuai; Johnson, Brianna; Raspe, Raphael; Schaefer-Babajew, Dennis; Shimeliovich, Irina; Daga, Mridushi; Yao, Kai-Hui; Schmidt, Fabian; Millard, Katrina G; Turroja, Martina; Jankovic, Mila; Oliveira, Thiago Y; Gazumyan, Anna; Caskey, Marina; Hatziioannou, Theodora; Bieniasz, Paul D; Nussenzweig, Michel C
Nature (London), 07/2022, Letnik: 607, Številka: 7917Journal Article
The Omicron variant of SARS-CoV-2 infected many vaccinated and convalescent individuals . Despite the reduced protection from infection, individuals who received three doses of an mRNA vaccine were highly protected from more serious consequences of infection . Here we examine the memory B cell repertoire in a longitudinal cohort of individuals receiving three mRNA vaccine doses . We find that the third dose is accompanied by an increase in, and evolution of, receptor-binding domain (RBD)-specific memory B cells. The increase is due to expansion of memory B cell clones that were present after the second dose as well as the emergence of new clones. The antibodies encoded by these cells showed significantly increased potency and breadth when compared with antibodies obtained after the second dose. Notably, the increase in potency was especially evident among newly developing clones of memory cells, which differed from persisting clones in targeting more conserved regions of the RBD. Overall, more than 50% of the analysed neutralizing antibodies in the memory compartment after the third mRNA vaccine dose neutralized the Omicron variant. Thus, individuals receiving three doses of an mRNA vaccine have a diverse memory B cell repertoire that can respond rapidly and produce antibodies capable of clearing even diversified variants such as Omicron. These data help to explain why a third dose of a vaccine that was not specifically designed to protect against variants is effective against variant-induced serious disease.
Avtor
![loading ... loading ...](themes/default/img/ajax-loading.gif)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|
Vir: Osebne bibliografije
in: SICRIS
To gradivo vam je dostopno v celotnem besedilu. Če kljub temu želite naročiti gradivo, kliknite gumb Nadaljuj.